The Gut Microbiota and Lipid Metabolism: Implications for Human Health and Coronary Heart Disease

By  

Current Medicinal Chemistry, Vol. 13, Iss. 25, 2006-10 ,pp. : 3005-3021

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial:primary Prevention of Coronary Heart Disease with Lipid Lowering Therapy

By Bernini F.   Paoletti R.  

Pharmacological Research, Vol. 35, Iss. 3, 1997-03 ,pp. : 167-167

Academic Press

Access to resources Recommend Favorite

Impact of Tobacco Smoking on Lipid Metabolism, Body Weight and Cardiometabolic Risk

By  

Current Pharmaceutical Design, Vol. 16, Iss. 23, 2010-08 ,pp. : 2526-2530

Bentham Science Publishers

Access to resources Recommend Favorite

Smoking habits, body mass index and risk of heart disease: prospective 2½-year follow-up of first episode schizophrenic patients

By Luty Jason   Kelly Ciara   McCreadie Robin G.  

Journal of Substance Use, Vol. 7, Iss. 1, 2002-04 ,pp. : 15-18

Radcliffe Press

Access to resources Recommend Favorite

Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease

By Nieminen Tuomo   Käähöönen Mika   Viiri Leena E   Gröönroos Paula   Lehtimääki Terho  

Pharmacogenomics, Vol. 9, Iss. 10, 2008-10 ,pp. : 1475-1486

Future Medicine

Access to resources Recommend Favorite